Pilot Clinical Trial: Insulin Therapy and Alzheimer's Disease
FYI:
http://archneur.ama-assn.org/cgi/con...eurol.2011.233 Archives of Neurology Published online September 12, 2011 Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial Suzanne Craft, PhD; Laura D. Baker, PhD; Thomas J. Montine, MD, PhD; Satoshi Minoshima, MD, PhD; G. Stennis Watson, PhD; Amy Claxton, PhD; Matthew Arbuckle, BA; Maureen Callaghan, MD; Elaine Tsai, MD; Stephen R. Plymate, MD; Pattie S. Green, PhD; James Leverenz, MD; Donna Cross, PhD; Brooke Gerton, MD Arch Neurol. Published online September 12, 2011. doi:10.1001/archneurol.2011.233 Note there were limitations to this pilot study |
I believe Pfizer stopped making intranasal insulin....
I could not find a product available in US currently. There was some problem with patient acceptance and delivery of the insulin was difficult to control and caused irritation etc. There has been discussion about a Type 3 diabetes existing in the brain. The brain makes insulin, surprisingly and this may fail. Implicated also in PD. You may also find this article interesting: http://www.diabetesincontrol.com/ind...rticle&id=2582 |
Wow, it was all over the news here today. Didn't have any idea the nasal spray wasn't made any more.
Thanks for the link. Very interesting indeed. |
http://scienceillustrated.com.au/blo...imers-disease/
New Treatment for Alzheimer's Disease. Science Illustrated Quote:
|
All times are GMT -5. The time now is 10:44 AM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.